跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTAMONE CHEWABLE TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
ACTAMONE CHEWABLE TABLET 5MG
Approved
THERAPEUTIC
ACTAMONE CHEWABLE TABLET 5MG
ACTAVIS LTD. (MALTA)
🇸🇬 Health Sciences Authority
Approval Date
May 25, 2016
Approval ID
25425655563762be
Company
ACTAVIS LTD. (MALTA)
Type
Therapeutic
Approval Details
Approval Id
25425655563762be
Drug Name
ACTAMONE CHEWABLE TABLET 5MG
Product Name
ACTAMONE CHEWABLE TABLET 5MG
Approval Number
SIN15015P
Approval Date
2016-05-25
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
Montelukast Sodium 5.20mg equivalent to Montelukast
5.00 mg
MONTELUKAST SODIUM 5.2 MG EQUIVALENT TO MONTELUKAST
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 25, 2016
Approval ID
25425655563762be
Type
Therapeutic
Back to HSA Approvals